Tianjin Medical Journal ›› 2022, Vol. 50 ›› Issue (10): 1026-1030.doi: 10.11958/20212081
• Experimental Research • Previous Articles Next Articles
TANG Yongjing1(), CHEN Yunfen1, LIAO Yue1, CHENG Qijiao1, ZHANG Guijuan1, WANG Yun2, HE Yihuai1,△(
)
Received:
2021-11-21
Revised:
2022-05-24
Published:
2022-10-15
Online:
2022-10-20
Contact:
HE Yihuai
E-mail:372828980@qq.com;993565989@qq.com
TANG Yongjing, CHEN Yunfen, LIAO Yue, CHENG Qijiao, ZHANG Guijuan, WANG Yun, HE Yihuai. Endotoxin exacerbates liver injury by down-regulating HNF4α expression[J]. Tianjin Medical Journal, 2022, 50(10): 1026-1030.
CLC Number:
组别 | n | ALT(U/L) | TBil(μmol/L) | ||
---|---|---|---|---|---|
对照组 | 12 | 42.08±5.53 | 1.28±0.15 | ||
0.5 mL/kg CCl4组 | 12 | 2 496.25±202.35a | 1.93±0.17a | ||
1.0 mL/kg CCl4组 | 12 | 4 458.00±506.94ab | 4.45±0.27ab | ||
2.0 mL/kg CCl4组 | 12 | 6 502.08±599.06abc | 6.35±0.69abc | ||
F | 493.724** | 404.139** | |||
组别 | HNF4α | Cleaved caspase-3 | |||
对照组 | 1.00±0.00 | 1.00±0.00 | |||
0.5 mL/kg CCl4组 | 1.95±0.05a | 1.71±0.11a | |||
1.0 mL/kg CCl4组 | 6.46±0.25ab | 5.55±0.21ab | |||
2.0 mL/kg CCl4组 | 11.48±0.43abc | 8.48±0.16abc | |||
F | 4 020.010** | 6 745.702** |
Tab. 1 Comparison of serum ALT and TBil levels, and protein expression levels of HNF4α and Cleaved caspase-3 in liver tissue between the four groups of mice induced by different doses of CCl4
组别 | n | ALT(U/L) | TBil(μmol/L) | ||
---|---|---|---|---|---|
对照组 | 12 | 42.08±5.53 | 1.28±0.15 | ||
0.5 mL/kg CCl4组 | 12 | 2 496.25±202.35a | 1.93±0.17a | ||
1.0 mL/kg CCl4组 | 12 | 4 458.00±506.94ab | 4.45±0.27ab | ||
2.0 mL/kg CCl4组 | 12 | 6 502.08±599.06abc | 6.35±0.69abc | ||
F | 493.724** | 404.139** | |||
组别 | HNF4α | Cleaved caspase-3 | |||
对照组 | 1.00±0.00 | 1.00±0.00 | |||
0.5 mL/kg CCl4组 | 1.95±0.05a | 1.71±0.11a | |||
1.0 mL/kg CCl4组 | 6.46±0.25ab | 5.55±0.21ab | |||
2.0 mL/kg CCl4组 | 11.48±0.43abc | 8.48±0.16abc | |||
F | 4 020.010** | 6 745.702** |
组别 | n | ALT(U/L) | TBil(μmol/L) | ||
---|---|---|---|---|---|
对照组 | 12 | 32.92±5.89 | 1.18±0.29 | ||
0.1 mg/kg LPS组 | 12 | 37.67±9.12 | 1.48±0.21 | ||
0.5 mg/kg LPS组 | 12 | 53.33±8.51 | 1.50±0.21 | ||
2.5 mg/kg LPS组 | 12 | 5 725.50±109.62abc | 5.44±0.22abc | ||
F | 29 112.963** | 836.544** | |||
组别 | HNF4α | Cleaved caspase-3 | |||
对照组 | 1.00±0.00 | 1.00±0.00 | |||
0.1 mg/kg LPS组 | 0.94±0.10 | 1.06±0.10 | |||
0.5 mg/kg LPS组 | 0.86±0.07 | 2.44±0.14 | |||
2.5 mg/kg LPS组 | 0.47±0.03abc | 7.40±0.16abc | |||
F | 156.332** | 7 022.815** |
Tab. 2 Comparison of serum ALT and TBil levels, and protein expression levels of HNF4α and Cleaved caspase-3 in liver tissue between the four groups of mice induced by different doses of LPS
组别 | n | ALT(U/L) | TBil(μmol/L) | ||
---|---|---|---|---|---|
对照组 | 12 | 32.92±5.89 | 1.18±0.29 | ||
0.1 mg/kg LPS组 | 12 | 37.67±9.12 | 1.48±0.21 | ||
0.5 mg/kg LPS组 | 12 | 53.33±8.51 | 1.50±0.21 | ||
2.5 mg/kg LPS组 | 12 | 5 725.50±109.62abc | 5.44±0.22abc | ||
F | 29 112.963** | 836.544** | |||
组别 | HNF4α | Cleaved caspase-3 | |||
对照组 | 1.00±0.00 | 1.00±0.00 | |||
0.1 mg/kg LPS组 | 0.94±0.10 | 1.06±0.10 | |||
0.5 mg/kg LPS组 | 0.86±0.07 | 2.44±0.14 | |||
2.5 mg/kg LPS组 | 0.47±0.03abc | 7.40±0.16abc | |||
F | 156.332** | 7 022.815** |
组别 | n | ALT(U/L) | TBil(μmol/L) | |||
---|---|---|---|---|---|---|
对照组 | 12 | 34.75±2.24 | 1.26±0.26 | |||
CCl4组 | 12 | 3 412.08±122.68a | 3.38±0.29a | |||
0.1 mg/kg LPS+CCl4组 | 12 | 5 683.00±177.65ab | 5.40±0.20ab | |||
0.5 mg/kg LPS+CCl4组 | 12 | 6 269.92±98.71ab | 6.28±0.16ab | |||
F | 6 236.269** | 1 011.176** | ||||
组别 | HNF4α | Cleaved caspase-3 | 凋亡指数 | |||
对照组 | 1.00±0.00 | 1.00±0.00 | 0.52±0.11 | |||
CCl4组 | 3.41±0.26a | 2.29±0.15a | 27.58±0.83a | |||
0.1 mg/kg LPS+CCl4组 | 2.45±0.14ab | 2.78±0.23ab | 31.93±0.73ab | |||
0.5 mg/kg LPS+CCl4组 | 1.55±0.08ab | 3.23±0.31ab | 36.71±0.82ab | |||
F | 513.070** | 238.550** | 6 101.197** |
Tab. 3 Comparison of serum ALT and TBil levels, protein expression levels of HNF4α and Cleaved caspase-3 in liver tissue and apoptotic index between the four groups
组别 | n | ALT(U/L) | TBil(μmol/L) | |||
---|---|---|---|---|---|---|
对照组 | 12 | 34.75±2.24 | 1.26±0.26 | |||
CCl4组 | 12 | 3 412.08±122.68a | 3.38±0.29a | |||
0.1 mg/kg LPS+CCl4组 | 12 | 5 683.00±177.65ab | 5.40±0.20ab | |||
0.5 mg/kg LPS+CCl4组 | 12 | 6 269.92±98.71ab | 6.28±0.16ab | |||
F | 6 236.269** | 1 011.176** | ||||
组别 | HNF4α | Cleaved caspase-3 | 凋亡指数 | |||
对照组 | 1.00±0.00 | 1.00±0.00 | 0.52±0.11 | |||
CCl4组 | 3.41±0.26a | 2.29±0.15a | 27.58±0.83a | |||
0.1 mg/kg LPS+CCl4组 | 2.45±0.14ab | 2.78±0.23ab | 31.93±0.73ab | |||
0.5 mg/kg LPS+CCl4组 | 1.55±0.08ab | 3.23±0.31ab | 36.71±0.82ab | |||
F | 513.070** | 238.550** | 6 101.197** |
[1] | SOLE C, SOLA E. Update on acute-on-chronic liver failure[J]. Gastroenterol Hepatol, 2018, 41(1):43-53. doi: 10.1016/j.gastrohep.2017.05.012. |
[2] | TANG Y J, CHEN H, YI Y, et al. Inhibition of eIF2α dephosphorylation protects hepatocytes from apoptosis by alleviating ER stress in acute liver injury[J]. Biomed Res Int, 2020, 2020:2626090. doi: 10.1155/2020/2626090. |
[3] | PEREGO J, BOURBON C, CHASSON L, et al. Guanabenz prevents d-Galactosamine/Lipopolysaccharide-induced liver damage and mortality[J]. Front Immunol, 2017, 8: 679. doi: 10.3389/fimmu.2017.00679. |
[4] | PEREA L, COLL M, SANJURJO L, et al. Pentraxin-3 modulates lipopolysaccharide-induced inflammatory response and attenuates liver injury[J]. Hepatology, 2017, 66(3):953-968. doi: 10.1002/hep.29215. |
[5] | LIU H, ZHANG W, DONG S, et al. Protective effects of sea buckthorn polysaccharide extracts against LPS/d-GalN-induced acute liver failure in mice via suppressing TLR4-NF-κB signaling[J]. J Ethnopharmacol, 2015, 176:69-78. doi: 10.1016/j.jep.2015.10.029. |
[6] | GABALLAH H H, EL-HORANY H E, HELAL D S. Mitigative effects of the bioactive flavonol fisetin on high-fat/high-sucrose induced nonalcoholic fatty liver disease in rats[J]. J Cell Biochem, 2019, 120(8):12762-12774. doi: 10.1002/jcb.28544. |
WANG B, CAI S R, GAO C, et al. Lipopolysaccharide results in a marked decrease in hepatocyte nuclear factor 4 alpha in rat liver[J]. Hepatology, 2001, 34(5):979-989. doi: 10.1242/jcs.114.6.1205. | |
[8] | BULLA G A, GIVENS E, BROWN S, et al. A common regulatory locus affects both HNF4/HNF1alpha pathway activation and sensitivity to LPS-mediated apoptosis in rat hepatoma cells[J]. J Cell Sci, 2001, 114(Pt 6):1205-1212. doi: 10.1053/jhep.2001.28885. |
[9] | SIMMONDS R C. Bioethics and animal use in programs of research,teaching,and testing[M]. In: WEICHBROD R H, THOMPSONG A, NORTONJ N. Management of animal care and use programs in research,education,and testing. 2nd ed. Boca Raton(FL): CRC Press/Taylor & Francis; 2018:35-62. doi: 10.1201/9781315152189-4. |
[10] | BRAHMANIA M, LIU S, WAHED A S. Alcohol,tobacco and coffee consumption and liver disease severity among individuals with chronic hepatitis B infection in North America[J]. Ann Hepatol, 2020, 19(4):437-445. doi: 10.1016/j.aohep.2020.01.005. |
[11] | FERNANDEZ J, ACEVEDO J, WIEST R, et al. Bacterial and fungal infections in acute-on-chronic liver failure:prevalence,characteristics and impact on prognosis[J]. Gut, 2018, 67(10):1870-1880. doi: 10.1136/gutjnl-2017-314240. |
[12] | SCHWABE R F, LUEDDE T. Apoptosis and necroptosis in the liver:a matter of life and death[J]. Nat Rev Gastroenterol Hepatol, 2018, 15(12):738-752. doi: 10.1038/s41575-018-0065-y. |
[13] | WANG P P, HUANG X, YANG M W, et al. Effects of non-drug treatment on liver cells apoptosis during hepatic ischemia-reperfusion injury[J]. Life Sci, 2021, 275:119321. doi: 10.1016/j.lfs.2021.119321. |
[14] | CHOI Y M, LEE S Y, KIM B J. Naturally occurring hepatitis B virus mutations leading to endoplasmic reticulum stress and their contribution to the progression of hepatocellular carcinoma[J]. Int J Mol Sci, 2019, 20(3):597. doi: 10.3390/ijms20030597. |
[15] | ZHAO X C, LIVINGSTON M J, LIANG X L, et al. Cell apoptosis and autophagy in renal fibrosis[J]. Adv Exp Med Biol, 2019, 1165:557-584. doi: 10.1007/978-981-13-8871-2_28. |
[16] | DUBOIS V, STAELS B, LEFEBVRE P, et al. Control of cell identity by the nuclear receptor HNF4 in organ pathophysiology[J]. Cells, 2020, 9(10):2185. doi: 10.3390/cells9102185. |
[17] | LIU W T, JING Y Y, GAO L, et al. Lipopolysaccharide induces the differentiation of hepatic progenitor cells into myofibroblasts constitutes the hepatocarcinogenesis-associated microenvironment[J]. Cell Death Differ, 2020, 27(1):85-101. doi: 10.1038/s41418-019-0340-7. |
[18] | CHEN S N, TAN Y, XIAO X C, et al. Deletion of TLR4 attenuates lipopolysaccharide-induced acute liver injury by inhibiting inflammation and apoptosis[J]. Acta Pharmacol Sin, 2021, 42(10):1610-1619. doi: 10.1038/s41401-020-00597-x. |
[19] | SUN J, ZHANG J, WANG X, et al. Gut-liver crosstalk in sepsis-induced liver injury[J]. Crit Care, 2020, 24(1):614. doi: 10.1186/s13054-020-03327-1. |
[20] | KUDRU C U, ESHWARA V K, NAGIRI S K, et al. Spectrum of bacterial infections and predictors of mortality in adult cirrhotic patients[J]. Med Pharm Rep, 2019, 92(4):356-361. doi: 10.15386/mpr-1387. |
[21] | CHENG Y J, YANG B C, LIU M Y. Lead increases lipopolysaccharide-induced liver-injury through tumor necrosis factor-alpha overexpression by monocytes/macrophages:role of protein kinase C and P42/44 mitogen-activated protein kinase[J]. Environ Health Perspect, 2006, 114(4):507-513. doi: 10.1289/ehp.8550. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||